The Social Security Administration has tasked the National Academies of Sciences, Engineering, and Medicine to review the latest published research and science and produce a report addressing best ...

Figure 10 Comparison of L150 Jameson cell mass pull versus recovery curve with 3-stage dilution and 2025 baseline rougher tests. VANCOUVER, British Columbia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- ...

Shares in 4D Medical have soared up to 33%, after the US FDA approved the company's CT:VQ lung imaging test ... Read More The post Health Check: 4D Medical wins ‘historic’ FDA clearance for lung ...

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN ...

Tamboran (B2) Pty Ltd. flow tested the Shenandoah S2-2H ST1 well and started the 2025 horizontal well drilling campaign in Beetaloo sub-basin, Northern Territory, Australia, said partner Falcon Oil & ...

Moderna’s shares rallied after the biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial. In early trading, the shares were 4.3% higher at $28.34, ...

June 10 (UPI) --China is positioning a satellite to test its ability to refuel another in orbit over Earth and extend its mission for several more years. China's Shijian-25 satellite is designed to ...

MARSHFIELD, Wis. (WSAW) - Wisconsin is now testing its dairies monthly for bird flu. Dairy farms say this does not change their day-to-day operations. At Nasonville Dairy in Marshfield, every batch of ...

As the only laboratory in the Northeast authorized by the USDA to test for bird flu, the Connecticut Veterinary Medical Diagnostic Laboratory on the University of Connecticut campus, is helping play a ...

Moderna has interim data it says support advancing its avian influenza vaccine into a late-stage clinical trial, but the U.S. government has canceled the federal contract that would have financed it, ...

The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu. The company said it ...